Please login to the form below

Not currently logged in

GCI Health opens new office in Hong Kong

Will be led by newly appointed director Yvonne Yeung

Yvonne Yeung

Yvonne Yeung will lead GCI Health's Hong Kong office

Integrated healthcare communications agency GCI health has expanded to Hong Kong, where it has officially opened a new office. 

The Hong Kong office will become its second opening in Asia-Pacific, after Singapore in January. It will be lead by the newly appointed director and market leader Yvonne Yeung (pictured above).

She joins GCI from The Hong Kong Council of Social Service, where she was the PR lead for various wide-scale healthy ageing and gerontechnology initiatives.

Prior to that, she was business director for Mind Resource Ogilvy, following Ogilvy’s acquisition of the specialist health communications firm she co-founded.

"Following a hugely successful year in Singapore, our flagship Asia Pacific hub office, our opening in Hong Kong and the appointment of Yvonne marks the start of a planned footprint expansion across the region, evolving our capacity to deliver regionally as well as locally in key markets," said Rikki Jones, Singapore-based regional managing director.Dan Blomfield

Also strengthening the GCI team is Dan Blomfield (pictured left), who has been appointed as managing director for the Singapore office, where he will oversee all operations.

Prior to this, he was managing director of Ogilvy Health Singapore, client service director for Singapore-based medical comms and HCP network MIMS and he also worked at health tech agency Icuna.

Earlier this year, GCI also expanded into Germany, after it acquired WPP sister agency Hering Schuppener Healthcare.

16th December 2019

From: Marketing


PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Jet Off with Maloff Protect

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...